MedPath

Imaging of Facial Neuritis

Conditions
Facial Neuritis
Registration Number
NCT03543384
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Improved means of positive diagnosis of facial neuritis, the leading cause of peripheral facial palsy

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age 18-80 years
  • Subject giving their consent for their participation
  • Patients with neuritis facial (neuritis group) who benefited, between 2009 and 2016, from an MRI of the internal auditory ducts, with gadolinous product injection and on the MRI 3 Tesla
  • Patients with a perception deafness, without neuritis sign (control group) who also benefited from an MRI with gadolinous product injection on the MRI 3T with the same protocol.
Exclusion Criteria
  • Refusal to participate in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presence or absence of pathologic enhancement of the facial nerve on the symptomatological side of the T2 sequence (FIESTA-C)1 hour after the realization of the MRI
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service Imagerie 1

🇫🇷

Strasbourg, France

Service Imagerie 1
🇫🇷Strasbourg, France
Francis VEILLON, MD, PhD
Principal Investigator
Aïna VENKATASAMY, MD, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.